首页 › 基金 › Palo Alto Investors LP › BMRN
Palo Alto Investors LP 对 BMRN 的持仓历史
BIOMARIN PHARMACEUTICAL INC · 医疗保健
Palo Alto Investors LP 在 Q3 2026 的 13F 申报中披露持有 BMRN(BIOMARIN PHARMACEUTICAL INC)642,455 股,市值约 US$38.5M,约占其申报组合的 5.73%,在其申报持仓中市值排名第 5 位。 Palo Alto Investors LP 最近 13 个申报季度中有 13 个季度披露了 BMRN 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Palo Alto Investors LP 对 BMRN 的持仓演变
Palo Alto Investors LP 于 Q3 2023 首次披露 BMRN 持仓:1,831,035 股(约 US$162.0M)。 在 13 次申报中,Palo Alto Investors LP 0 次增持、10 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 642,455 股、市值约 US$38.5M,环比减持 -40,322 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 1.83M | $162.01M | 新进 |
| Q4 2023 | 1.50M | $144.70M | 减持 |
| Q1 2024 | 1.13M | $99.09M | 减持 |
| Q2 2024 | 1.13M | $93.05M | 持有 |
| Q3 2024 | 1.09M | $76.62M | 减持 |
| Q4 2024 | 1.07M | $70.15M | 减持 |
| Q1 2025 | 991.21K | $70.07M | 减持 |
| Q2 2025 | 840.47K | $46.20M | 减持 |
| Q3 2025 | 754.01K | $40.84M | 减持 |
| Q4 2025 | 746.26K | $44.35M | 减持 |
| Q1 2026 | 685.18K | $38.71M | 减持 |
| Q2 2026 | 682.78K | $39.07M | 持有 |
| Q3 2026 | 642.46K | $38.55M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BMRN 与 13F 数据
BMRN(BIOMARIN PHARMACEUTICAL INC)属于医疗保健行业。我们追踪的基金中还有 27 只申报持有 BMRN,申报仓位最大的包括:PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), 维京环球投资 (US$435.8M), VIKING GLOBAL INVESTORS LP (US$430.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BMRN 的基金
- PRIMECAP MANAGEMENT CO/CA/ 14.99M 股 · $899.34M · Q3 2026
- 维京环球投资 7.62M 股 · $435.82M · Q2 2026
- VIKING GLOBAL INVESTORS LP 7.17M 股 · $430.39M · Q3 2026
- Deep Track Capital, LP 6.37M 股 · $382.46M · Q3 2026
- Vestal Point Capital, LP 5.53M 股 · $331.50M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 2.03M 股 · $121.51M · Q3 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 111.50M 股 · $109.58M · Q3 2026
更多关于 Palo Alto Investors LP
常见问题
How long has Palo Alto Investors LP held BMRN?
Palo Alto Investors LP has disclosed BMRN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Palo Alto Investors LP's current position in BMRN?
As of Q3 2026, Palo Alto Investors LP holds 642.46K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $38.55M, representing 5.73% of its reported portfolio and ranking #5.
Has Palo Alto Investors LP been buying or selling BMRN?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP reduced its position in BMRN.
Which other funds hold BMRN?
Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, 维京环球投资, VIKING GLOBAL INVESTORS LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.